Home - Products - Others - Other Targets - Citenamide

Citenamide

CAS No. 10423-37-7

Citenamide( —— )

Catalog No. M33319 CAS No. 10423-37-7

Citenamide (AY-15613) has anticancer and anticonvulsant activity and is used in the study of neurological disorders because of its sleep-promoting properties.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	248	Get Quote
5MG	312	Get Quote
10MG	528	Get Quote
25MG	994	Get Quote
50MG	1334	Get Quote
100MG	1764	Get Quote
500MG	3528	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Citenamide
Note

Research use only, not for human use.
Brief Description

Citenamide (AY-15613) has anticancer and anticonvulsant activity and is used in the study of neurological disorders because of its sleep-promoting properties.
Description

Citenamide is an anticonvulsant.
In Vitro

——
In Vivo

Citenamide (Cytenamide, CYT) is an analogue of Carbamazepine (CBZ), a dibenzazepine drug used to control seizures.
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

10423-37-7
Formula Weight

235.28
Molecular Formula

C16H13NO
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C(N)C1C=2C=CC=CC2C=CC=3C=CC=CC31
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Johnston A, et al. Cytenamide-formic acid (1/1). Acta Crystallogr Sect E Struct Rep Online. 2008 Jul 5;64(Pt 8):o1379-80.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

α-D-Galactose-1-phos...

Galactose 1-phosphate is an intermediate in the galactose metabolism and nucleotide sugars metabolism pathways.
BDNF (human)

Member of the neurotrophin growth factor family that binds and activates TrkB and p75 neurotrophin receptors. Enhances the survival, growth and differentiation of neurons. BDNF expression is altered in neurodegenerative disorders such as Parkinson's and Alzheimer's disease.
m-PEG4-SH

m-PEG4-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Sign In Join Free